MedKoo Cat#: 584738 | Name: ML-1035 free base

Description:

WARNING: This product is for research use only, not for human or veterinary use.

ML 1035 is a benzamide that elicits contractions from guinea-pig non-stimulated ileum.

Chemical Structure

ML-1035 free base
ML-1035 free base
CAS#54504-71-1 (free base)

Theoretical Analysis

MedKoo Cat#: 584738

Name: ML-1035 free base

CAS#: 54504-71-1 (free base)

Chemical Formula: C18H19ClN4O6

Exact Mass: 422.0993

Molecular Weight: 422.82

Elemental Analysis: C, 51.13; H, 4.53; Cl, 8.38; N, 13.25; O, 22.70

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Synonym
ML-1035; ML1035; ML 1035;
IUPAC/Chemical Name
Acetic acid, (4-chlorophenoxy)-, 2-hydroxy-3-(1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-7H-purin-7-yl)propyl ester
InChi Key
YMCNTAHTWKEECY-UHFFFAOYSA-N
InChi Code
InChI=1S/C18H19ClN4O6/c1-21-16-15(17(26)22(2)18(21)27)23(10-20-16)7-12(24)8-29-14(25)9-28-13-5-3-11(19)4-6-13/h3-6,10,12,24H,7-9H2,1-2H3
SMILES Code
O=C(OCC(O)CN1C=NC(N(C)C(N2C)=O)=C1C2=O)COC3=CC=C(Cl)C=C3
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 422.82 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Mandagere AK, Osborne DR, Vaughn V, Kuo BS, Thompson TN, Chang J, Battor JL, Geary JI, Hwang KK. Determination of ML-1035 enantiomers in plasma by chiral high-performance liquid chromatography. J Pharm Biomed Anal. 1991;9(10-12):797-803. PubMed PMID: 1822197. 2: Linnik MD, Butler BT, Elsea SH, Ahmed NK. Analysis of neurogenic contractions induced by ML-1035 and other benzamides in the guinea-pig non-stimulated isolated ileum. J Pharm Pharmacol. 1994 Jun;46(6):491-6. PubMed PMID: 7932045. 3: Kuo BS, Poole JC, Mandagere A, Hwang KK. Column-switching liquid chromatographic determination of ML-1035 sulphoxide and its sulphone and sulphide metabolites in rat urine. J Pharm Biomed Anal. 1991;9(10-12):935-40. PubMed PMID: 1822215. 4: Kuo BS, Poole JC, Mandagere AK, Hwang KK. Disposition kinetics of ML-1035 sulfoxide enantiomers and the prochiral sulfide in rats. Chirality. 1993;5(6):428-35. PubMed PMID: 8398602. 5: Rao N, Otis KW, Hwang KK. Sex-differences in the disposition of substituted benzamides: pharmacokinetics of a gastroprokinetic agent (4-amino-5-chloro-2-[2- (methylsulfinyl) ethoxy]-N-[2-(diethylamino)ethyl] benzamide hydrochloride) (ML-1035) in male and female New Zealand white rabbits. Biopharm Drug Dispos. 1992 Dec;13(9):681-91. PubMed PMID: 1467455. 6: Kuo BS, Poole JC, Hwang KK. Validation of a column-switching high-performance liquid chromatographic (HPLC) method for determination of ML-1035 and its five metabolites in plasma. Pharm Res. 1992 Jan;9(1):119-25. PubMed PMID: 1589396. 7: Linnik MD, Butler BT, Gaddis RR, Ahmed NK. Analysis of serotonergic mechanisms underlying benzamide-induced gastroprokinesis. J Pharmacol Exp Ther. 1991 Nov;259(2):501-7. PubMed PMID: 1941605. 8: Butler BT, Silvey G, Houston DM, Borcherding DR, Vaughn VL, McPhail AT, Radzik DM, Wynberg H, ten Hoeve W, van Echten E, et al. The resolution, isolation, and pharmacological characterization of the enantiomers of a benzamide containing a chiral sulfoxide. Chirality. 1992;4(3):155-62. PubMed PMID: 1586586. 9: Kuo BS, Poole JC, Hwang KK, Cheng H. Determination of bioavailability and systemically available fractions of drugs undergoing reversible metabolism: application to 4-amino-5-chloro-2-[2-(methylsulfinyl)ethoxy]-N-[2- (diethylamino)ethyl]benzamide and its sulfide and sulfone metabolites in rats. J Pharm Sci. 1994 Mar;83(3):386-90. PubMed PMID: 8207687. 10: Kuo BS, Poole JC, Hwang KK, Cheng H. Pharmacokinetics and metabolic interconversion of intravenous 4-amino-5-chloro-2-[(methylsulfinyl)ethoxy]-N-[2-(diethylamino)ethyl] benzamide and its sulfide and sulfone metabolites in rats. J Pharm Sci. 1993 Jul;82(7):694-8. PubMed PMID: 8360842.